Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 27.85
-0.75 (-2.62%)
Oct 20, 2026, 1:24 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.07 billion as of October 20, 2026. It is the 25,655th most valuable company in the world and the 1,391st biggest in Taiwan. Its market cap has increased by 5.06% in one year.
Market Cap
3.07B
Enterprise Value
4.26B
Revenue
48.55M
Global Rank
Country Rank
#1,391 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.07B, a decrease of -23.27%. That is a compound annual growth rate of -2.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 3.07B | 5.95% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.83B |
| Pharmosa Biopharm | 3.61B |
| SYN-TECH Chem. & Pharm. | 3.42B |
| Great Novel Therapeutics Biotech & Medicals | 3.33B |
| Shine-On BioMedical | 3.30B |
| BioGend Therapeutics | 3.28B |
| Sagittarius Life Science | 3.16B |
| Senhwa Biosciences | 3.00B |